Please enable Javascript to use all features and improve your user experience.
EHC 2022
Programme
Posters
People
Search
EN
All people
Jennifer Madonia
Sort by Type
Date
Further involvements
09 Dec
15:40
–
15:45
3 Min.
2 Min.
ePoster
P104
A Phase 2/3 Open-label, Long-term, Safety Trial of Zavegepant 10 mg Nasal Spray for the Acute Treatment of Migraine
CGRP inhibitors in the clinic, Migraine
09 Dec
16:50
–
16:55
3 Min.
2 Min.
ePoster
P136a
Efficacy and Safety of Zavegepant Nasal Spray for the Acute Treatment of Migraine: Results of a Phase 3 Double-Blind, Randomized, Placebo Controlled Trial
CGRP inhibitors in the clinic, Migraine
v1.19.0
© Conventus Congressmanagement & Marketing GmbH
Imprint
Privacy